Skip to content

Drug interactions

Sotorasib + Ticagrelor

Severity: Moderate

Sotorasib and Ticagrelor: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Sotorasib is a weak P-glycoprotein inhibitor and can modestly increase exposure to P-gp substrates such as ticagrelor. This could slightly increase the bleeding tendency, though the effect is likely small. The legacy direction (decrease) is not supported by the mechanism.

What this interaction means in plain words

Sotorasib and Ticagrelor can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Sotorasib belongs to Oncology; Ticagrelor belongs to Cardiovascular.

Evidence level: Low

Why it happens

Sotorasib inhibits P-glycoprotein, which may reduce efflux of ticagrelor and increase its exposure.

What to do

Monitor for bleeding and bruising when starting sotorasib in a patient taking ticagrelor.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Sotorasib and Ticagrelor, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Sotorasib with Ticagrelor?

MediHelp rates the interaction as moderate. Sotorasib and Ticagrelor can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Sotorasib is a weak P-glycoprotein inhibitor and can modestly increase exposure to P-gp substrates such as ticagrelor. This could slightly increase the bleeding tendency, though the effect is likely small. The legacy direction (decrease) is not supported by the mechanism.

How serious is the interaction between Sotorasib and Ticagrelor?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for bleeding and bruising when starting sotorasib in a patient taking ticagrelor.

What other medicines interact with Ticagrelor?

MediHelp also lists interactions of Ticagrelor with, for example, Itraconazole, Ketoconazole, Levoketoconazole. The full list is on the Ticagrelor page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in